Related Experiment Video
Updated: Aug 8, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Published on: June 5, 2015
Modified immune globulin: its use in the prophylactic treatment of patients with immune deficiency
Patients with antibody deficiency syndromes provide excellent models to study safety and efficacy of new immune globulin (IG) preparations for intravenous use. In a long term study of such patients we showed that a reduced and alkylated IG preparation given intravenously was as effective in preventing infections as Cohn fraction II given intramuscularly. Mild side effects occurred in 50% of infusions; addition of maltose reduced side effects to 3%. Adverse reactions appeared to be related to IG concentration: they were slightly higher if the IG concentration was increased from 5% to 10%. The striking effect of maltose may relate to the observation that maltose and other disaccharides, added to Cohn fraction II, prevent heat aggregation in vitro. The stabilizing effect of these sugars was most pronounced at pH 6-6.5. Thus, modified IG formulated as a 5% solution in 10% maltose seems to be safe, effective and suitable for rapid intravenous infusion.
Patients with antibody deficiency syndromes provide excellent models to study safety and efficacy of new immune globulin (IG) preparations for intravenous use. In a long term study of such patients we showed that a reduced and alkylated IG preparation given intravenously was as effective in preventing infections as Cohn fraction II given intramuscularly. Mild side effects occurred in 50% of infusions; addition of maltose reduced side effects to 3%. Adverse reactions appeared to be related to IG concentration: they were slightly higher if the IG concentration was increased from 5% to 10%. The striking effect of maltose may relate to the observation that maltose and other disaccharides, added to Cohn fraction II, prevent heat aggregation in vitro. The stabilizing effect of these sugars was most pronounced at pH 6-6.5. Thus, modified IG formulated as a 5% solution in 10% maltose seems to be safe, effective and suitable for rapid intravenous infusion.
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Microorganisms in Medicine and Therapeutics

